PA
ATRA icon

Parallel Advisors’s Atara Biotherapeutics ATRA Stock Holding History

Parallel Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25
Closed -$1.82K – 3365
2023
Q1 		$1.82K Sell
25
-17
-40% -$1.65K ﹤0.01% 2803
2022
Q4 		$3.43K Buy
42
+38
+950% +$3.96K ﹤0.01% 2480
2022
Q3 		$0 Buy
+4
New +$449 ﹤0.01% 3131
2022
Q2 		– Sell
-8
Closed -$2K – 2984
2022
Q1 		$2K Sell
8
-5
-38% -$1.59K ﹤0.01% 2545
2021
Q4 		$5K Buy
13
+5
+63% +$2.1K ﹤0.01% 2371
2021
Q3 		$4K Hold
8
– – ﹤0.01% 2428
2021
Q2 		$3K Hold
8
– – ﹤0.01% 2429
2021
Q1 		$3K Hold
8
– – ﹤0.01% 2330
2020
Q4 		$4K Hold
8
– – ﹤0.01% 2074
2020
Q3 		$3K Hold
8
– – ﹤0.01% 2169
2020
Q2 		$3K Buy
+8
New +$2.02K ﹤0.01% 2065
2020
Q1 		– Sell
-2
Closed -$1K – 2385
2019
Q4 		$1K Buy
+2
New +$690 ﹤0.01% 2284

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return